Source and scope
This summary applies to previously healthy Canadian children older than 2 months with suspected community-acquired bacterial meningitis. Neonates, adults, cerebrospinal-fluid shunts, immunocompromise and hospital-acquired infection require separate pathways.
sources for this section:CPS meningitis
Source-attributed clinical priorities
- Treat suspected bacterial meningitis in a child older than 2 months as an emergency; classic meningeal features may be absent.
- Obtain blood cultures and cerebrospinal fluid when safe, but do not delay empiric antimicrobial treatment when lumbar puncture cannot be performed promptly.
- Review treatment when organism and susceptibility results become available and arrange audiology and complication follow-up.
- In a previously healthy child older than 2 months, suspected bacterial meningitis requires prompt empiric treatment even when classic meningeal findings are absent.
sources for this section:CPS meningitis
Practical assessment and management workflow
1
Assess airway, consciousness, perfusion, neck stiffness, rash, seizure and focal neurologic findings.
2
Obtain appropriately sized blood cultures before treatment when this does not delay antimicrobial administration.
3
Perform lumbar puncture promptly when safe; if it cannot be performed, give empiric treatment and transfer to a facility able to complete the assessment.
4
Review antimicrobials when culture, molecular and susceptibility results return, and arrange hearing and complication follow-up.
sources for this section:CPS meningitis
Safety, red flags and urgent escalation
- Shock, purpura, reduced consciousness or rapidly evolving illness needs emergency critical-care support.
- Do not delay antimicrobials because lumbar puncture or transfer is delayed.
- Neonates, cerebrospinal-fluid shunts, hospital-acquired infection and immunocompromise fall outside this pathway and need specialist guidance.
sources for this section:CPS meningitis
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CPS meningitis
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CPS meningitis
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Paediatric SocietyGuidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than 2 months of agePosted 2020-10-19; reaffirmed 2026-01-12 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.